Literature DB >> 17371680

[Clinical picture of 8th pair schwannoma. Is it expressive enough?].

Enrique Coscarón Blanco1, Angel Muñoz Herrera, José Manuel Serradilla López, Angel Maillo Sánchez, Juan Carlos Paniagua Escudero.   

Abstract

OBJECTIVE: To describe the stage-related clinical features of 8th cranial nerve schwannoma. MATERIAL AND
METHOD: Descriptive study of 71 patients whose diagnosis and/or treatment have been carried out at our centre between 1997-2003. Gender, age, and symptoms were considered, with special attention to gender. Determination of tumoral stage following Tos and Thomsen image criteria.
RESULTS: The mean age was 64.6 (range, 20-87) with a marked incidence between 52 and 70 years (62 % of the whole), slightly higher in females and in the left ear. The main symptoms were those derived from involvement of the 7th and 8th cranial nerves, with other cranial nerves and cerebello-pontine structures being involved in larger tumours, although a high variability was noted in clinical patterns of same-stage cases and in the first symptom. Our study also found a high variability in hearing conservation and a marked frequency of vestibular or facial (motor and sensory) symptoms. There were also very infrequent forms of presentation that are highlighted.
CONCLUSIONS: There is no typical clinical pattern and no typical first symptom in 8th cranial nerve schwannomas. Any audiovestibular or facial symptom, even the slightest, may be the first expression of 8th cranial nerve schwannoma. There is no stage-specific symptom except for those with involvement of the cerebello-pontine or cerebral structures.

Entities:  

Mesh:

Year:  2007        PMID: 17371680

Source DB:  PubMed          Journal:  Acta Otorrinolaringol Esp        ISSN: 0001-6519


  1 in total

1.  Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor in the Cerebellopontine Angle : Diagnosis and Treatment.

Authors:  Ho Yong Choi; Yong Hwy Kim; Jee Hyun Kim; In Ah Kim; Gheeyoung Choe; Chae-Yong Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.